Skip to Main Content

Paper Details

Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression.
PLoS ONE
79
2018
-responsive genes, CD4+, CD8+, IA, Ipilimumab, Nivolumab, Nivolumab gene, Nivolumab gene signature, OA, PD-1, PD-L1, PD-L2, PD1, Pembrolizumab, RA, anti-PD-1, anti-cytotoxic T lymphocyte-associated antigen (CTLA)-4, anti-programmed death (PD)-, arthralgia, cancer, inflammatory arthritis, patients, programmed death ligand-1, rheumatoid arthritis, s, serum sPD-1, synovial tissue, undifferentiated arthritis
Author NameAffiliation
Alice M Walsh
Michele BombardieriQueen Mary University of London
Frances HumbyQueen Mary University of London
Costantino PitzalisQueen Mary University of London
Sunil Nagpal
  • 1 - 5

Datasets

Release 1.2